The three aspirin doses did not significantly impact the biosynthesis of PGE2in vivo evaluated by assessing urinary PGEM and PGE2 in colorectal tissue, presumably explained by the variable and incomplete impact of aspirin, at any dose, to acetylate COX-2 at Serine 516 in CRC tissue. The gene discussed is PTGS2; the disease is colorectal carcinoma.